Zurcher Kantonalbank Zurich Cantonalbank Sells 89 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Zurcher Kantonalbank Zurich Cantonalbank decreased its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 1.3% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,532 shares of the medical instruments supplier’s stock after selling 89 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in ICU Medical were worth $907,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ICUI. Dimensional Fund Advisors LP increased its holdings in shares of ICU Medical by 18.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier’s stock worth $83,788,000 after acquiring an additional 82,982 shares during the last quarter. Northern Trust Corp increased its holdings in shares of ICU Medical by 11.1% in the fourth quarter. Northern Trust Corp now owns 402,342 shares of the medical instruments supplier’s stock valued at $62,431,000 after purchasing an additional 40,187 shares during the last quarter. Point72 Asset Management L.P. increased its holdings in shares of ICU Medical by 63.2% in the fourth quarter. Point72 Asset Management L.P. now owns 245,340 shares of the medical instruments supplier’s stock valued at $38,069,000 after purchasing an additional 95,030 shares during the last quarter. Oberweis Asset Management Inc. raised its position in shares of ICU Medical by 20.1% in the fourth quarter. Oberweis Asset Management Inc. now owns 156,680 shares of the medical instruments supplier’s stock valued at $24,312,000 after purchasing an additional 26,180 shares during the period. Finally, Victory Capital Management Inc. lifted its stake in shares of ICU Medical by 5.7% during the 1st quarter. Victory Capital Management Inc. now owns 149,246 shares of the medical instruments supplier’s stock worth $20,724,000 after buying an additional 8,101 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

ICU Medical Price Performance

Shares of ICU Medical stock opened at $129.02 on Wednesday. The company has a 50-day simple moving average of $130.61 and a two-hundred day simple moving average of $141.08. ICU Medical, Inc. has a twelve month low of $119.19 and a twelve month high of $196.26. The stock has a market capitalization of $3.18 billion, a price-to-earnings ratio of -33.69 and a beta of 0.88. The company has a quick ratio of 1.52, a current ratio of 2.59 and a debt-to-equity ratio of 0.75.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share for the quarter, beating analysts’ consensus estimates of $1.23 by $0.49. The company had revenue of $599.49 million during the quarter, compared to the consensus estimate of $574.15 million. ICU Medical had a negative net margin of 3.87% and a positive return on equity of 6.75%. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.96 earnings per share. Analysts forecast that ICU Medical, Inc. will post 4.11 EPS for the current year.

Analyst Upgrades and Downgrades

ICUI has been the topic of a number of research reports. Wall Street Zen upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Sunday, May 18th. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research report on Tuesday, April 8th. KeyCorp lowered their target price on ICU Medical from $209.00 to $191.00 and set an “overweight” rating on the stock in a research note on Monday, April 21st. Finally, Raymond James Financial dropped their price target on ICU Medical from $197.00 to $187.00 and set a “strong-buy” rating for the company in a report on Friday, May 9th. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $192.67.

Insider Buying and Selling

In other news, insider Ben Sousa sold 2,000 shares of the stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $137.36, for a total transaction of $274,720.00. Following the sale, the insider directly owned 479 shares of the company’s stock, valued at approximately $65,795.44. This represents a 80.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director David C. Greenberg sold 1,942 shares of the business’s stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $143.66, for a total value of $278,987.72. Following the completion of the transaction, the director directly owned 6,760 shares of the company’s stock, valued at approximately $971,141.60. This trade represents a 22.32% decrease in their position. The disclosure for this sale can be found here. Insiders sold 36,097 shares of company stock valued at $4,860,156 over the last 90 days. 1.50% of the stock is currently owned by insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.